2014 Grant Awards
The posters and papers listed below each grant arise from work facilitated through the grant funding.
Development and usability testing of a personalized risk communication tool to facilitate the shared decision of methotrexate treatment options in early rheumatoid arthritis
Principal Investigator: Hazlewood, G. (PDF)
Co-investigators: Marshall, D.; Barnabe, C.; Li, L.; Bansback, N.; Bykerk, V.; Tugwell, P.
The grant was used to develop a decision tool to help patients with newly diagnosed rheumatoid arthritis choose between methotrexate and ‘triple therapy’, two commonly used treatment options. The tool combines the best evidence about these treatment options, and walks patients through a series of questions to help them reach a decision that is consistent with their preferences. The tool is currently undergoing final testing. Once finalized, it will be made available patients and physicians free of charge at https://decideapp.org/.
Impact and Outcomes
Recognition of the importance of considering patients’ preferences in healthcare treatment is growing, and this project has allowed us to develop a practical tool that to help facilitate the physician-patient discussion. We believe that this tool will provide a valuable resource to assist patients in making an evidence-informed decision that is consistent with their individual values.
American College of Rheumatology Annual Meeting, San Francisco, California, November 6-11, 2015, Enhancing Comparative Effectiveness Research by Combining Observational and Randomized Trial Data to Personalize the Choice Between Methotrexate and Triple Therapy for Methotrexate-naïve Patients with Early Rheumatoid Arthritis, Hazlewood. G., Barnabe, C., Boire, G., Hitchon, C., Keystone, E., Haraoui, B., Thorne, C., Tin, D., Pope, J., Lin, D., Bykerk, V., and CATCH investigators.
Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study, Patient Preference and Adherence, (May 2020)